ACP recommends shortening the antibiotic treatment time for common bacterial infections
Time of Update: 2021-04-19
Urinary tract infection ➤For female patients with simple bacterial cystitis, use a short course of antibiotic treatment: nitrofurantoin for 5 days, trimethoprim-sulfamethoxazole (TMP-SMZ) for 3 days, or fosfomycin as a single dose medicine.
Which common bacterial infections are recommended for short-term antibiotic treatment?
Time of Update: 2021-04-18
For COPD, the GOLD guidelines recommend that patients with clinical symptoms of bacterial infection (such as difficulty breathing, purulent sputum and/or increased sputum volume) use antibiotics to treat COPD exacerbation.
Antibiotic treatment for children with pneumonia, the short course of treatment is equivalent to the long course of treatment?
Time of Update: 2021-03-26
A recent study showed that a 5-day course of antibiotics is as effective as a standard 10-day course in the treatment of community-associated pneumonia in non-hospitalized children.
The clinical results of phase 3 of the treatment of pneumonia with a new combination of antibiotics in Mercedon came out
Time of Update: 2021-03-03
The results showed that Recarbrio showed statistically non-poor statistical effectiveness in terms of all-cause mortality and clinical response on the 28th day compared to pyracillin/tazobactam (PIP/TAZ) in terms of the main endpoints and secondary endpoints of the study.
A variety of antibiotic courses are associated with the failure of pediatric treatment
Time of Update: 2021-02-16
, a postdoctoral researcher at Baylor College of Medicine, told Parent-Child Science. He continued, "This healthy bacterial population is called the microbiome. Damaged microbiomes can cause harmful bacteria to overgrow and cause harm. ”（cyy123.com）
JAMA: Antibiotic treatment for simple appendicitis - full oral vs injection combined oral treatment
Time of Update: 2021-01-22
For patients with CT-confirmed simple appendicitis, antibiotic therapy is a safe, effective, feasible and cost-effective alternative to surgical treatment. 2020 guidelines of the World Society of Emergency Surgery recommend antibiotics
NEJM: Avoid "knife-to-knife" part of appendicitis patients may consider antibiotic treatment.
Time of Update: 2020-10-30
, a large randomized controlled trial published in the New England Journal of Medicine (NEJM) showed that antibiotics may be a good treatment option for some patients with appendicitis.
World J Gastroenterology: Two-day treatment of enema antibiotics can eradicate parasitic infections and relieve them.
Time of Update: 2020-10-01
This is a retrospective longitudinal study that treated 54 patients (over the age of 18) who were positive for human Bifidobacteria and libido infections with rectal tri-antibiotics for two consecutive days.
The new antibiotic Contepo's treatment for complex urinary tract infections was again rejected by the FDA.
Time of Update: 2020-07-29
Nabriva Therapeutics, a biopharmaceutical company dedicated to the development of innovative anti-infective drugs for serious infections, announced that it has received a full response from the FDA (CRL) to reject the application for a new drug (NDA
Treatment of hospital-acquired bacterial pneumonia Mersadon innovative antibiotic approved by FDA
Time of Update: 2020-06-27
the safety and efficacy of Recarbrio's treatment of HABP/VABP was tested in a randomized controlled clinical trial of habP/VABP hospitalized patients with 535 cases of Gram-negative bacterial infection.
Lancet Infect Dis: Acute simple cystitis antibiotic treatment can be shortened
Time of Update: 2020-06-24
For third- and fourth-generation fluoroquinolones, the clinical efficacy of the 3-day scenario was similar to that of a single-dose protocol (risk ratio of 0.99 vs 1.024), with medium quality of evidence.
JAMA: CRP-directed, 7-day or 14-day antibiotic regimen for the treatment of Gram-negative mystemia
Time of Update: 2020-06-24
studies showed that for adult patients with Gram-negative mycomosis, there was no significant difference in clinical efficacy of 30 days between CRP-directed antibiotic treatment and 7-day treatment regimens compared to 14-day treatment syllas.
Astellas antibiotic new product Dafclir has been approved in Japan for the treatment of infectious enteritis
Time of Update: 2020-06-11
recently announced that the new product (fidaxomicin, non-damycin) has been approved in Japan to treat infectious enteritis (including pseudo-membrane colitis (PMC), the Japanese pharmaceutical company Astellas announced.
FDA approves Nabriva's innovative antibiotic Xenleta (lefamulin) for use in treatment of CABP
Time of Update: 2020-06-08
Community Acquired Bacterial Pneumonia (CABP), a bacterial pneumonia that is developed outside the hospital environment, is one of the most common infectious diseases that threatens health ( population.
Yan Noi's new antibiotic cefiderocol treatment hospital obtained pneumonia adult patients 3 study reached the main endpoint
Time of Update: 2020-06-08
recently, Japan's Shionogi company ( announced that it had developed a new antibiotic, cefiderocol, to reach the main endpoint of the experimental (
FDA approves RedHill antibiotic drug Talicia for treatment of adult patients infected with Helicobacter pylori
Time of Update: 2020-06-07
recently, ( of bio pharmaceutical ( announced that its of the antibiotic drug was approved for the fda ( to treat adult patients infected with Helicobacter pylori.
Treatment of multi-drug-resistant bacterial pneumonia New antibiotics are expected to be approved this year
Time of Update: 2020-06-01
Hospital-acquired pneumonia caused by Gram-negative bacteria(including E. coli, Gyeeloba, and Kiwi-variant bacteria) is a serious bacterial infection that often occurs in critical and susceptible hospital populations. Antibiotic resistance
Redhill antibiotic talicia is approved by FDA for the treatment of adult Helicobacter pylori infection
Time of Update: 2019-11-18
On November 18, 2019, the arterial network (micro signal: vcpeat) learned from the external media information that red hill biopharma (Redhill), a biopharma company, announced
Zerbaxa, a new antibiotic of MSD, has been approved by FDA for the treatment of adult bacterial pneumonia
Time of Update: 2019-06-05
On February 12, 2019, FDA accepted Merck's supplementary new drug application (SNDA) for compound antibiotic product zerbaxa (ceftolozane / tazobactam), and granted the product
J. Exp. Med: antibiotic treatment can reduce Alzheimer's symptoms in male mice
Time of Update: 2019-05-18
May 18, 2019 / Biovalley / University of Chicago researchers have shown that the type of bacteria living in the gut can affect the development of Alzheimer's symptoms in mice